Form 4: Quoin Pharmaceuticals Director Buys Shares
Insider Transaction (Form 4)
Anthony James Culverwell, a Director of Quoin Pharmaceuticals, Ltd., purchased 9,219 shares of common stock on August 31, 2026 for $4.88 per share.
Summary
- Open-market purchase: acquired 6,146 ADSs at $4.88 ($29,992) on August 31, 2026; holds 40,364 after (Direct).
- Open-market purchase: acquired 3,073 Ordinary Warrants (Right to Buy) on August 31, 2026; holds 3,073 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $29,992, committing personal capital to the stock.
Insider Transactions
Anthony James Culverwell — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Open-market purchase | ADSs | 6,146 | $5 | $30.0K | 40,364 |
| 2026-08-31 | Open-market purchase | Ordinary Warrants (Right to Buy) | 3,073 | — | — | 3,073 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Open-market purchase (6,146 shares) |
| 2026-08-31 | Open-market purchase (3,073 shares) |
Keywords
insider transaction, Form 4, QNRX, Quoin Pharmaceuticals, Ltd., bullish, Anthony James Culverwell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.